This whole pharmaceutical advertising thing is driving me crazy. Pharma ads today read like investor relations documents: they contain thousands of words, are dense, unintelligible, full of obfuscation and blather. Has anyone other than a lawyer and proofreader really ever read one of these print ads stem to stern(um?)
Today Merck issued it a counterpoint ad telling readers not to believe a recent study questioning the combined efficacy of cholesterol drugs Zetia and Vytorin. Give it a read, if you have an extra hour.
I’m old school. I want my doctor to proscribe medicine and to know about and believe in that medicine. I don’t want to make the decision after having read 10,000 words of gibberish, that includes a side effect, such as “in rare cases, your Homer Simpson might turn green.”
When we have socialized medicine, I certainly don’t want competition to diminish – a serious possibility — but reducing all of the spending on direct to consumer pharma ads should cut about 25% of the cost. Sometimes, it seems, too much competition isn’t good.
Possibly Related Posts:
- NFL and Marketing Futures.
- Reach and Free-quency
- Life Imitating the Internet.
- Poor Sprint.
- A Tale of Apple and Yahoo.
Tags: home simpson, merck, pharmaceutical advertising, vytorin, whats the idea. wall street journal, zetia












Recent Comments